- Intergenic splicing of MDS1 and EVI1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR domain family. Fears, S., Mathieu, C., Zeleznik-Le, N., Huang, S., Rowley, J.D., Nucifora, G. Proc. Natl. Acad. Sci. U.S.A. (1996)
- Fusion of ETV6 to MDS1/EVI1 as a result of t(3;12)(q26;p13) in myeloproliferative disorders. Peeters, P., Wlodarska, I., Baens, M., Criel, A., Selleslag, D., Hagemeijer, A., Van den Berghe, H., Marynen, P. Cancer Res. (1997)
- Human AML1/MDS1/EVI1 fusion protein induces an acute myelogenous leukemia (AML) in mice: a model for human AML. Cuenco, G.M., Nucifora, G., Ren, R. Proc. Natl. Acad. Sci. U.S.A. (2000)
- Targeted Degradation of the AML1/MDS1/EVI1 Oncoprotein by Arsenic Trioxide. Shackelford, D., Kenific, C., Blusztajn, A., Waxman, S., Ren, R. Cancer Res. (2006)
- 16S rDNA sequence and phylogenetic position of an uncultivated spirochete from the hindgut of the termite Mastotermes darwiniensis Froggatt. Berchtold, M., Ludwig, W., König, H. FEMS Microbiol. Lett. (1994)
- Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Ott, M.G., Schmidt, M., Schwarzwaelder, K., Stein, S., Siler, U., Koehl, U., Glimm, H., Kühlcke, K., Schilz, A., Kunkel, H., Naundorf, S., Brinkmann, A., Deichmann, A., Fischer, M., Ball, C., Pilz, I., Dunbar, C., Du, Y., Jenkins, N.A., Copeland, N.G., Lüthi, U., Hassan, M., Thrasher, A.J., Hoelzer, D., von Kalle, C., Seger, R., Grez, M. Nat. Med. (2006)
- The leukaemia-associated transcription factors EVI-1 and MDS1/EVI1 repress transcription and interact with histone deacetylase. Vinatzer, U., Taplick, J., Seiser, C., Fonatsch, C., Wieser, R. Br. J. Haematol. (2001)
- A novel gene, MEL1, mapped to 1p36.3 is highly homologous to the MDS1/EVI1 gene and is transcriptionally activated in t(1;3)(p36;q21)-positive leukemia cells. Mochizuki, N., Shimizu, S., Nagasawa, T., Tanaka, H., Taniwaki, M., Yokota, J., Morishita, K. Blood (2000)
- Establishment of a novel human myeloid leukaemia cell line (HNT-34) with t(3;3)(q21;q26), t(9;22)(q34;q11) and the expression of EVI1 gene, P210 and P190 BCR/ABL chimaeric transcripts from a patient with AML after MDS with 3q21q26 syndrome. Hamaguchi, H., Suzukawa, K., Nagata, K., Yamamoto, K., Yagasaki, F., Morishita, K. Br. J. Haematol. (1997)
- Recurrent retroviral vector integration at the Mds1/Evi1 locus in nonhuman primate hematopoietic cells. Calmels, B., Ferguson, C., Laukkanen, M.O., Adler, R., Faulhaber, M., Kim, H.J., Sellers, S., Hematti, P., Schmidt, M., von Kalle, C., Akagi, K., Donahue, R.E., Dunbar, C.E. Blood (2005)
- Quantitative analysis of bone marrow CD34 cells in aplastic anemia and hypoplastic myelodysplastic syndromes. Matsui, W.H., Brodsky, R.A., Smith, B.D., Borowitz, M.J., Jones, R.J. Leukemia (2006)
- The leukemia-associated transcription repressor AML1/MDS1/EVI1 requires CtBP to induce abnormal growth and differentiation of murine hematopoietic cells. Senyuk, V., Chakraborty, S., Mikhail, F.M., Zhao, R., Chi, Y., Nucifora, G. Oncogene (2002)
- Quantitative comparison of the expression of EVI1 and its presumptive antagonist, MDS1/EVI1, in patients with myeloid leukemia. Vinatzer, U., Mannhalter, C., Mitterbauer, M., Gruener, H., Greinix, H., Schmidt, H.H., Fonatsch, C., Wieser, R. Genes Chromosomes Cancer (2003)
- Rearrangement of the AML1/CBFA2 gene in myeloid leukemia with the 3;21 translocation: expression of co-existing multiple chimeric genes with similar functions as transcriptional repressors, but with opposite tumorigenic properties. Zent, C., Kim, N., Hiebert, S., Zhang, D.E., Tenen, D.G., Rowley, J.D., Nucifora, G. Curr. Top. Microbiol. Immunol. (1996)
- Multipoint interphase FISH analysis of chromosome 3 abnormalities in 28 childhood AML patients. Haltrich, I., Kost-Alimova, M., Kovács, G., Klein, G., Fekete, G., Imreh, S. Eur. J. Haematol. (2006)
- A European interlaboratory testing of three well-known procedures for immunocytochemical detection of epithelial cells in bone marrow. Results from analysis of normal bone marrow. Borgen, E., Pantel, K., Schlimok, G., M??ller, P., Otte, M., Renolen, A., Ehnle, S., Coith, C., Nesland, J.M., Naume, B. Cytometry. Part B, Clinical cytometry. (2006)
- High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients. Barjesteh van Waalwijk van Doorn-Khosrovani, S., Erpelinck, C., van Putten, W.L., Valk, P.J., van der Poel-van de Luytgaarde, S., Hack, R., Slater, R., Smit, E.M., Beverloo, H.B., Verhoef, G., Verdonck, L.F., Ossenkoppele, G.J., Sonneveld, P., de Greef, G.E., Löwenberg, B., Delwel, R. Blood (2003)